sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)), Indication (Asthma and COPD), End User (Patients and R and D) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder...

Home / Categories / Healthcare
Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)), Indication (Asthma and COPD), End User (Patients and R and D) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Smart Inhalers Market by Product...
Report Code
RO1/113/1061

Publish Date
01/Sep/2016

Pages
202
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Key Findings

3.2.1 Top Winning Strategies
3.2.2 Top Investment Pockets

3.3 Porters Five Forces Analysis

3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of Substitutes
3.3.4 Threat of New Entrants
3.3.5 Intensity of Competitive Rivalry

3.4 Top Player Positioning, 2015
3.5 Clinical Trials
3.6 Product Portfolio
3.7 Market Dynamics

3.7.1 Drivers

3.7.1.1 Global increase in air pollution
3.7.1.2 Increase in population susceptible to indoor air pollutants
3.7.1.3 Increasing prevalence of COPD and asthma globally
3.7.1.4 Expected increase in adherence to smart inhalers
3.7.1.5 Increasing collaboration between pharmaceutical companies and smart inhaler manufacturers
3.7.1.6 Rising incidences of chronic conditions

3.7.2 Restraints

3.7.2.1 Misusing data and data privacy
3.7.2.2 Availability of smart inhalers
3.7.2.3 Overall high cost of asthma and COPD treatment
3.7.2.4 Resistance towards adoption of smart inhalers

3.7.3 Opportunities

3.7.3.1 Increased focus towards advanced treatment protocols
3.7.3.2 Significant unmet need in respiratory care
3.7.3.3 Increased awareness to reduce healthcare costs
3.7.3.4 Opportunities in emerging economies

CHAPTER 4 SMART INHALERS MARKET, BY PRODUCT, 2014-2022

4.1 Overview

4.1.1 Market Size and Forecast

4.2 Inhalers

4.2.1 Key Market Trends
4.2.2 Growth Factors and Opportunities
4.2.3 Market Size and Forecast
4.2.4 Dry Powder Inhalers (DPIs)
4.2.5 Metered Dose Inhalers (MDIs)

4.3 Nebulizers

4.3.1 Key Market Trends
4.3.2 Growth Factors and Opportunities
4.3.3 Market Size and Forecast

CHAPTER 5 SMART INHALERS MARKET, BY INDICATION, 2014-2022

5.1 Overview

5.1.1 Market Size and Forecast

5.2 Asthma

5.2.1 Market Size and Forecast

5.3 COPD

5.3.1 Market Size and Forecast

CHAPTER 6 SMART INHALERS MARKET, BY END USER, 2014-2022

6.1 Overview

6.1.1 Market Size and Forecast

6.2 Patients

6.2.1 Market Size and Forecast

6.3 R&D

6.3.1 Market Size and Forecast

CHAPTER 7 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022

7.1 Overview

7.1.1 Market Size and Forecast

7.2 North America

7.2.1 Key Market Trends
7.2.2 Growth Factors and Opportunities
7.2.3 Market Size and Forecast

7.2.3.1 U.S.: Market Size and Forecast
7.2.3.2 Canada: Market Size and Forecast
7.2.3.3 Mexico: Market Size and Forecast

7.3 Europe

7.3.1 Key Market Trends
7.3.2 Growth Factors and Opportunities
7.3.3 Market Size and Forecast

7.3.3.1 Germany: Market Size and Forecast
7.3.3.2 UK: Market Size and Forecast
7.3.3.3 France: Market Size and Forecast
7.3.3.4 Italy: Market Size and Forecast
7.3.3.5 Russia: Market Size and Forecast

7.4 Asia-Pacific

7.4.1 Key Market Trends
7.4.2 Growth Factors and Opportunities
7.4.3 Market Size and Forecast

7.4.3.1 Japan: Market Size and Forecast
7.4.3.2 China: Market Size and Forecast
7.4.3.3 India: Market Size and Forecast
7.4.3.4 Australia: Market Size and Forecast
7.4.3.5 Rest of Asia-Pacific: Market Size and Forecast

7.5 LAMEA (Latin America, Middle East, and Africa)

7.5.1 Key Market Trends
7.5.2 Growth Factors and Opportunities
7.5.3 Market Size and Forecast

7.5.3.1 Brazil: Market Size and Forecast
7.5.3.2 Turkey: Market Size and Forecast
7.5.3.3 Saudi Arabia: Market Size and Forecast
7.5.3.4 UAE: Market Size and Forecast
7.5.3.5 Rest of Lamea: Market Size and Forecast

CHAPTER 8 COMPANY PROFILES

8.1 Adherium Limited

8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Operating Business Segments
8.1.4 Business Performance
8.1.5 Key Strategic Moves and Developments

8.2 Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)

8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Operating Business Segments
8.2.4 Business Performance
8.2.5 Key Strategic Moves and Developments

8.3 Propeller Health

8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Operating Business Segments
8.3.4 Business Performance
8.3.5 Key Strategic Moves and Developments

8.4 Cohero Health, LLC

8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating Business Segments
8.4.4 Business Performance
8.4.5 Key Strategic Moves and Developments

8.5 OPKO Health, Inc. (Inspiro Medical Ltd.)

8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4 Business Performance
8.5.5 Key Strategic Moves and Developments

8.6 GlaxoSmithKline plc

8.6.1 Company Overview
8.6.2 Operating Business Segments
8.6.3 Business Performance
8.6.4 Key Strategic Moves and Developments

8.7 Novartis AG

8.7.1 Company Overview
8.7.2 Operating Business Segments
8.7.3 Business Performance
8.7.4 Key Strategic Moves and Developments

8.8 AstraZeneca plc

8.8.1 Company Overview
8.8.2 Operating Business Segments
8.8.3 Business Performance
8.8.4 Key Strategic Moves and Developments

8.9 Boehringer Ingelheim GmbH

8.9.1 Company Overview
8.9.2 Operating Business Segments
8.9.3 Business Performance
8.9.4 Key Strategic Moves and Developments

8.10 Vectura Group plc

8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Operating Business Segments
8.10.4 Business Performance
8.10.5 Key Strategic Moves and Developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com